总剂量、分量剂量和呼吸运动管理对肾上腺 SBRT 治疗效果的影响

IF 2.7 3区 医学 Q3 ONCOLOGY
Ory Haisraely , Ilana Weiss , Marcia Jaffe , Sarit Appel , Orit Person-Kaidar , Zvi Symon , Maoz Ben-Ayun , Sergi Dubinski , Yaacov Lawrence
{"title":"总剂量、分量剂量和呼吸运动管理对肾上腺 SBRT 治疗效果的影响","authors":"Ory Haisraely ,&nbsp;Ilana Weiss ,&nbsp;Marcia Jaffe ,&nbsp;Sarit Appel ,&nbsp;Orit Person-Kaidar ,&nbsp;Zvi Symon ,&nbsp;Maoz Ben-Ayun ,&nbsp;Sergi Dubinski ,&nbsp;Yaacov Lawrence","doi":"10.1016/j.ctro.2024.100788","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose/Objective(s)</h3><p>Stereotactic body radiotherapy (SBRT) is an effective treatment for oligometastatic disease in multiple sites. However, the optimal radiation dose for long-term local control of adrenal metastases has yet to be determined. The aim of this study is to evaluate outcomes of adrenal SBRT and to evaluate factors that correlate with local control.</p></div><div><h3>Materials/Methods</h3><p>After IRB approval, a retrospective data review of patients treated with SBRT for adrenal metastases at a medical center in Israel between 2015 and 2021 was conducted. A biological effective dose was calculated using an alpha beta ratio of 10. Kaplan Meier and Cox regression were calculated using SPSS software to describe the hazard ratio for local control and survival.</p></div><div><h3>Results</h3><p>83 cases of adrenal SBRT were identified. The average age was 67 (range 42–92 years old). Non-small cell lung cancer was the primary site in 44 % of patients. A total of 70 % of the patients had oligometastatic disease (less than five lesions), and the rest were polymetastatic, responding to systemic therapy with oligo progression in the adrenal. The average gross tumor volume (GTV) was 42 ml. Respiratory control was applied in 88 % of cases; 49.3 % used 4-D/ITV, and 38.5 % used breath-hold or continuous positive airway pressure (CPAP) with free breathing. On multivariable analysis, Dose above 75 Gy (biological effective Dose) (HR = 0.41, p = 0.031), Dose above 8 Gy per fraction (HR = 0.53p = 0.038), and breath-holds or CPAP (HR = 0.65, p = 0.047) were significant for local control. From multivariable analysis, we computed a predicted nomogram curve using seven clinical parameters to evaluate local control odds.</p></div><div><h3>Conclusion</h3><p>In this single institution series reported to date, we found unilateral adrenal SBRT safe, yet bilateral treatment harbors a risk of adrenal insufficiency. Biological effective Dose &gt; 75 Gy (BED), motion management with breath-hold or CPAP, and Dose per fraction &gt; 8 Gy were the enhanced local controls. We propose a nomogram to help in decision-making regarding total Dose and Dose per fraction when treating adrenal SBRT.</p></div>","PeriodicalId":10342,"journal":{"name":"Clinical and Translational Radiation Oncology","volume":"47 ","pages":"Article 100788"},"PeriodicalIF":2.7000,"publicationDate":"2024-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S240563082400065X/pdfft?md5=1b63256e44f65b1dac8c5416b27c1d9e&pid=1-s2.0-S240563082400065X-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Total dose, fraction dose and respiratory motion management impact adrenal SBRT outcome\",\"authors\":\"Ory Haisraely ,&nbsp;Ilana Weiss ,&nbsp;Marcia Jaffe ,&nbsp;Sarit Appel ,&nbsp;Orit Person-Kaidar ,&nbsp;Zvi Symon ,&nbsp;Maoz Ben-Ayun ,&nbsp;Sergi Dubinski ,&nbsp;Yaacov Lawrence\",\"doi\":\"10.1016/j.ctro.2024.100788\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose/Objective(s)</h3><p>Stereotactic body radiotherapy (SBRT) is an effective treatment for oligometastatic disease in multiple sites. However, the optimal radiation dose for long-term local control of adrenal metastases has yet to be determined. The aim of this study is to evaluate outcomes of adrenal SBRT and to evaluate factors that correlate with local control.</p></div><div><h3>Materials/Methods</h3><p>After IRB approval, a retrospective data review of patients treated with SBRT for adrenal metastases at a medical center in Israel between 2015 and 2021 was conducted. A biological effective dose was calculated using an alpha beta ratio of 10. Kaplan Meier and Cox regression were calculated using SPSS software to describe the hazard ratio for local control and survival.</p></div><div><h3>Results</h3><p>83 cases of adrenal SBRT were identified. The average age was 67 (range 42–92 years old). Non-small cell lung cancer was the primary site in 44 % of patients. A total of 70 % of the patients had oligometastatic disease (less than five lesions), and the rest were polymetastatic, responding to systemic therapy with oligo progression in the adrenal. The average gross tumor volume (GTV) was 42 ml. Respiratory control was applied in 88 % of cases; 49.3 % used 4-D/ITV, and 38.5 % used breath-hold or continuous positive airway pressure (CPAP) with free breathing. On multivariable analysis, Dose above 75 Gy (biological effective Dose) (HR = 0.41, p = 0.031), Dose above 8 Gy per fraction (HR = 0.53p = 0.038), and breath-holds or CPAP (HR = 0.65, p = 0.047) were significant for local control. From multivariable analysis, we computed a predicted nomogram curve using seven clinical parameters to evaluate local control odds.</p></div><div><h3>Conclusion</h3><p>In this single institution series reported to date, we found unilateral adrenal SBRT safe, yet bilateral treatment harbors a risk of adrenal insufficiency. Biological effective Dose &gt; 75 Gy (BED), motion management with breath-hold or CPAP, and Dose per fraction &gt; 8 Gy were the enhanced local controls. We propose a nomogram to help in decision-making regarding total Dose and Dose per fraction when treating adrenal SBRT.</p></div>\",\"PeriodicalId\":10342,\"journal\":{\"name\":\"Clinical and Translational Radiation Oncology\",\"volume\":\"47 \",\"pages\":\"Article 100788\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-05-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S240563082400065X/pdfft?md5=1b63256e44f65b1dac8c5416b27c1d9e&pid=1-s2.0-S240563082400065X-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical and Translational Radiation Oncology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S240563082400065X\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Translational Radiation Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S240563082400065X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的/目标:立体定向体放射治疗(SBRT)是治疗多部位少转移性疾病的有效方法。然而,肾上腺转移瘤长期局部控制的最佳放射剂量尚未确定。本研究旨在评估肾上腺 SBRT 的疗效,并评估与局部控制相关的因素。材料/方法经 IRB 批准后,对 2015 年至 2021 年期间在以色列一家医疗中心接受 SBRT 治疗的肾上腺转移患者进行了回顾性数据审查。生物有效剂量以阿尔法-贝塔比10计算。使用 SPSS 软件计算了 Kaplan Meier 和 Cox 回归,以描述局部控制和生存的危险比。平均年龄为 67 岁(42-92 岁不等)。44%的患者的原发部位为非小细胞肺癌。70%的患者为少转移性疾病(少于5个病灶),其余为多转移性疾病,对全身治疗有反应,但肾上腺少转移。肿瘤平均总体积(GTV)为42毫升。88%的病例采用呼吸控制;49.3%的病例使用4-D/ITV,38.5%的病例使用屏气或持续气道正压(CPAP)配合自由呼吸。在多变量分析中,剂量高于 75 Gy(生物有效剂量)(HR = 0.41,p = 0.031)、每分量剂量高于 8 Gy(HR = 0.53p = 0.038)、屏气或 CPAP(HR = 0.65,p = 0.047)对局部控制有显著影响。通过多变量分析,我们使用七个临床参数计算了预测提名图曲线,以评估局部控制几率。结论在迄今为止报告的这一单机构系列中,我们发现单侧肾上腺 SBRT 是安全的,但双侧治疗存在肾上腺功能不全的风险。生物有效剂量大于 75 Gy (BED)、通过屏气或 CPAP 进行运动管理以及每分剂量大于 8 Gy 是增强局部控制的方法。我们提出了一个提名图,以帮助在肾上腺 SBRT 治疗时就总剂量和每分剂量做出决策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Total dose, fraction dose and respiratory motion management impact adrenal SBRT outcome

Purpose/Objective(s)

Stereotactic body radiotherapy (SBRT) is an effective treatment for oligometastatic disease in multiple sites. However, the optimal radiation dose for long-term local control of adrenal metastases has yet to be determined. The aim of this study is to evaluate outcomes of adrenal SBRT and to evaluate factors that correlate with local control.

Materials/Methods

After IRB approval, a retrospective data review of patients treated with SBRT for adrenal metastases at a medical center in Israel between 2015 and 2021 was conducted. A biological effective dose was calculated using an alpha beta ratio of 10. Kaplan Meier and Cox regression were calculated using SPSS software to describe the hazard ratio for local control and survival.

Results

83 cases of adrenal SBRT were identified. The average age was 67 (range 42–92 years old). Non-small cell lung cancer was the primary site in 44 % of patients. A total of 70 % of the patients had oligometastatic disease (less than five lesions), and the rest were polymetastatic, responding to systemic therapy with oligo progression in the adrenal. The average gross tumor volume (GTV) was 42 ml. Respiratory control was applied in 88 % of cases; 49.3 % used 4-D/ITV, and 38.5 % used breath-hold or continuous positive airway pressure (CPAP) with free breathing. On multivariable analysis, Dose above 75 Gy (biological effective Dose) (HR = 0.41, p = 0.031), Dose above 8 Gy per fraction (HR = 0.53p = 0.038), and breath-holds or CPAP (HR = 0.65, p = 0.047) were significant for local control. From multivariable analysis, we computed a predicted nomogram curve using seven clinical parameters to evaluate local control odds.

Conclusion

In this single institution series reported to date, we found unilateral adrenal SBRT safe, yet bilateral treatment harbors a risk of adrenal insufficiency. Biological effective Dose > 75 Gy (BED), motion management with breath-hold or CPAP, and Dose per fraction > 8 Gy were the enhanced local controls. We propose a nomogram to help in decision-making regarding total Dose and Dose per fraction when treating adrenal SBRT.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology Medicine-Radiology, Nuclear Medicine and Imaging
CiteScore
5.30
自引率
3.20%
发文量
114
审稿时长
40 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信